企業プロフィール
Gossamer Bio 株価・ニュース・カタリスト
- ティッカー:
- GOSS
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.17 USD (+13.12%)
終値
最終更新: 2026年8月24日
47M USD
時価総額
株価変動の要因
As of Aug 24, 2026, GOSS closed up 13.1% at $0.1750. No new same-company headline was identified in the current news window.
企業概要
事業概要
Gossamer Bio is a biotechnology company focused on pulmonary and inflammatory disease. Its programs aim to address serious conditions in areas where targeted therapies can matter.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Gossamer sits in specialty biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, target validation, and the ability to build a focused respiratory and inflammation franchise.
バイオ業界での位置付け
Gossamer is a catalyst-sensitive specialty name whose stock reacts to data, strategy, and execution.
今後のカタリスト
- Gossamer’s catalysts are seralutinib and the pulmonary-hypertension program, with the next update deciding whether the inhaled therapy can still build momentum. The company needs clean clinical progress to keep the story moving.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。